Angela Lamarca: Great news for patients diagnosed with Biliary Malignancies and HCC in Spain

Angela Lamarca: Great news for patients diagnosed with Biliary Malignancies and HCC in Spain

Angela Lamarca, Consultant in Medical Oncology at Jiménez Díaz Foundation University Hospital, shared a post on X:

“Great news for patients diagnosed with Biliary Malignancies and HCC in Spain.

Recommendation to fund Durvalumab:

  1. Biliary: in combination with CisGem chemotherapy
  2. HCC: in combination with Tremelimumab.

Great start of the weekend!”

Angela Lamarca: Great news for patients diagnosed with Biliary Malignancies and HCC in Spain

Source: Angela Lamarca/X

Angela Lamarca Biliary Malignancies cancer CisGem chemotherapy Durvalumab HCC hepatocellular carcinoma Jiménez Díaz Foundation University Hospital OncoDaily Oncology Tremelimumab